$FITX news CEN Biotech Inc. (FITX) Notifies Health

New Post Public Reply Private Reply Replies (0) Message Board
fitzkarz
$FITX news

CEN Biotech Inc. (FITX) Notifies Health Canada that it’s facility is Ready for the Pre-License Inspection

MADISON HEIGHTS, MI / ACCESSWIRE / April 30, 14, 2014 / Creative Edge Nutrition, Inc. (PINKSHEETS: FITX), is proud to announce that it has notified Health Canada that its facility is ready for the Pre-License inspection. The company accelerated its construction and build-out plans for what will become the world’s largest and most advanced legal cannabis production facility.

Bill Chaaban stated “it is important for our company to receive its license from Health Canada as soon as possible. To fulfill this goal, we have redesigned the layout of our standing 27,000 square foot building to become a self-sustained complete operational production facility. It will have all of the state of the art technologies implemented into the design of our larger facility. This building will be completely compliant with our obligations as promised to Health Canada. We are proud to advise that on April 22, 2014 we notified Health Canada that our facility would be ready for the Pre-License Inspection. On April 29, 2014, we notified Health Canada that stage one of the facility was completed and is now ready for the pre-license inspection. As the company waits for the pre-license inspection, it will continue the build-out of the 53,000 square foot facility. We have implemented cGMP and USP 797 design and work flow models into the design and build-out of our buildings.”

About CEN Biotech

CEN Biotech, Inc. was established in 2013 as a partially owned subsidiary of Creative Edge Nutrition (OTC Pink: FITX) for the sole purpose of supplying the Canadian public with pharmaceutical-grade medical cannabis under the newly established Marihuana for Medical Purposes Regulations (MMPR) CEN Biotech Inc. has submitted a comprehensive application to become a licensed producer (LP) of dried marihuana for medicinal purposes and has received a ready-to-build approval from Health Canada.

About Creative Edge Nutrition, Inc.
Creative Edge Nutrition is a holding company and a Nutritional Supplement Company focused on developing innovative, high quality supplements. The company offers a broad spectrum of capsules, tablets, and powders, as well as science based products in the principal categories of weight management, nutrition challenges, energy and fitness. The Company manufactures under strict GMP guidelines at GMP Certified and/or FDA registered facilities. www.CenergyNutrition.com and https://www.facebook.com/CenergyNutrition

FOR INVESTOR RELATIONS, Please Contact: William Swalm (212) 584-4342 Email: Info@cenergynutrition.com

Source: Creative Edge Nutrition, Inc

Source: Accesswire (April 30, 2014 - 8:36 AM EDT)

News by QuoteMedia
I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 14

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 17

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 12

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 11

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 12

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Semtech Corporation Faces Legal Challenge: Shareholder Rights Explained

Updated Category News Views 145

Understanding the Current Legal Landscape for Semtech Corporation Semtech Corporation, a notable player in the semiconductor industry, is currently embroiled in a significant class action lawsuit concerning alleged violations of federal securities laws. This legal action has garnered the attention of investors and shareholders alike, prompting them to seek clarity on...

Continue Reading
Breezeline Expands Fiber Internet Access in New Hampshire

Updated Category News Views 194

Breezeline's Commitment to Fiber Internet Expansion Breezeline is actively enhancing its service offerings by deploying fiber-to-the-home internet in several communities across New Hampshire. This exciting initiative aims to connect towns such as Barnstead, Farmington, Franklin, Milton, Northfield, Pittsfield, Rochester, Tilton, and Wolfeboro with high-speed internet. As...

Continue Reading
Investigation into Cepton, Inc.'s Share Sale: What's Next for Investors?

Updated Category News Views 78

Cepton, Inc. (NASDAQ: CPTN) got itself tangled in a mess back when it sold to KOITO MANUFACTURING CO., LTD. for $3.17 per share. Traders were quick on the draw as Halper Sadeh LLC kicked off an investigation into whether that price was just or a complete rip-off for shareholders. The heart of the issue? Was Cepton’s board really looking out for their shareholders’...

Continue Reading
Affordable 5G Solutions for Low-Income Households Set to Transform Lives

Updated Category News Views 218

Mission Telecom Partners with Computers 4 People This innovative partnership is set to eliminate significant barriers to affordable broadband for low-income households. By dramatically reducing hardware costs, these organizations aim to transform internet access across communities. An Unprecedented Move Towards Digital Equity The collaboration between Mission Telecom and...

Continue Reading
KPN's Strategy and Progress on €250 Million Share Buyback

Updated Category News Views 139

KPN's Strategic Share Buyback Initiative KPN is making notable strides with its €250 million share buyback program. Recently, the company repurchased a significant amount of its ordinary shares from March 24 to March 28. This specific buyback involved 2,020,000 shares, purchased at an average price of €3.84 per share, totaling approximately €7.8 million. These...

Continue Reading